Eve Burstein
Stock Analyst at Bernstein
(2.89)
# 2,671
Out of 4,829 analysts
22
Total ratings
75%
Success rate
20.96%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $135 → $145 | $115.55 | +25.49% | 3 | Jan 10, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $157.29 | +27.15% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $98.50 | +47.21% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $366.67 | -1.82% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $53.40 | +68.54% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $41.66 | -15.99% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $432.59 | +43.32% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.10 | +127.27% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $13.00 | +69.23% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $81.57 | +36.08% | 1 | Sep 28, 2023 |
Agilent Technologies
Jan 10, 2025
Maintains: Market Perform
Price Target: $135 → $145
Current: $115.55
Upside: +25.49%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $157.29
Upside: +27.15%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $98.50
Upside: +47.21%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $366.67
Upside: -1.82%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $53.40
Upside: +68.54%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $41.66
Upside: -15.99%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $432.59
Upside: +43.32%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.10
Upside: +127.27%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $13.00
Upside: +69.23%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $81.57
Upside: +36.08%